Select Medical Holdings Corporation (NYSE:SEM) shares fell to a low of $36.18 before closing at $37.74. Intraday shares traded counted 0.68 million, which was 10.18% higher than its 30-day average trading volume of 760.93K. SEM’s previous close was $37.56 while the outstanding shares total 130.33M. The firm has a beta of 1.41, a 12-month trailing P/E ratio of 16.07, and a growth ratio of 0.90. The stock’s Relative Strength Index (RSI) is 56.79, with weekly volatility at 3.08% and ATR at 1.15. The SEM stock’s 52-week price range has touched low of $13.51 and a $39.76 high. The stock traded higher over the last trading session, gaining 0.48% on 05/19/21.
Investors have identified the Medical Care Facilities company Select Medical Holdings Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $5.05 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Select Medical Holdings Corporation (SEM) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For SEM, the company has in raw cash 750.27 million on their books with 15.43 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 1.84 billion total, with 1.54 billion as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 2.86 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on SEM sounds very interesting.
Is the stock of SEM attractive?
In related news, Vice President, Compliance, Breighner Robert G. JR sold 5,040 shares of the company’s stock in a transaction that recorded on May 10. The sale was performed at an average price of 37.07, for a total value of 186,833. As the sale deal closes, the Director, Ely James S. III now sold 5,644 shares of the company’s stock, valued at 197,653. Also, Director, Ely James S. III sold 4,656 shares of the company’s stock in a deal that was recorded on Mar 12. The shares were price at an average price of 35.01 per share, with a total market value of 163,007. Following this completion of acquisition, the Director, Ely James S. III now holds 9,700 shares of the company’s stock, valued at 339,694. In the last 6 months, insiders have changed their ownership in shares of company stock by 4.90%.
4 out of 5 analysts covering the stock have rated it a Buy, while 1 have maintained a Hold recommendation on Select Medical Holdings Corporation. 0 analysts has assigned a Sell rating on the SEM stock. The 12-month mean consensus price target for the company’s shares has been set at $39.40.